Trial · NCT01584518
B-type Natriuretic Peptide as a Surrogate Marker Guiding Post-operative Fluid Off-loading
NCT01584518, Not applicable, Completed, Creighton University; results first posted 2016-03-28
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. B-type Natriuretic Peptide as a Surrogate Marker Guiding Post-operative Fluid Off-loading. Trials, record NCT01584518. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01584518
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- B-type Natriuretic Peptide as a Surrogate Marker Guiding Post-operative Fluid Off-loading
- NCT number
- NCT01584518
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 50 participants, actual
- Lead sponsor
- Creighton University
- Conditions
- Fluid Over-load
- Interventions
- Furosemide
- First posted
- 2012-04-25
- Last updated
- 2016-05-27
- Results first posted
- 2016-03-28
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Length of Stay | From date of admission until date of discharge, assessed up to 1 month | The subjects will be evaluated preoperatively and followed post-operatively until discharge from the hospital. Length of stay |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Length of Stay | From date of admission until date of discharge, assessed up to 1 month | days | MEAN |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Length of Stay | CHF Peptide | 4 | Standard Deviation 3 | days | |
| Length of Stay | Non CHF Peptide | 6 | Standard Deviation 5 | days |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | CHF Peptide | 25 | |
| Overall Study | STARTED | Non CHF Peptide | 25 | |
| Overall Study | COMPLETED | CHF Peptide | 25 | |
| Overall Study | COMPLETED | Non CHF Peptide | 25 | |
| Overall Study | NOT COMPLETED | CHF Peptide | 0 | |
| Overall Study | NOT COMPLETED | Non CHF Peptide | 0 |
Source ClinicalTrials.gov
Adverse events4
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | Acute renal failure | Renal and urinary disorders | CHF Peptide | 0 | 25 | 0 |
| serious | Acute renal failure | Renal and urinary disorders | Non CHF Peptide | 2 | 25 | 2 |
| serious | Death | Cardiac disorders | CHF Peptide | 0 | 25 | 0 |
| serious | Death | Cardiac disorders | Non CHF Peptide | 2 | 25 | 2 |
Source ClinicalTrials.gov
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | CHF Peptide | ||
| Total, all-cause mortality | Non CHF Peptide | ||
| Total, other adverse events | CHF Peptide | 0 | 25 |
| Total, other adverse events | Non CHF Peptide | 0 | 25 |
| Total, serious adverse events | CHF Peptide | 0 | 25 |
| Total, serious adverse events | Non CHF Peptide | 4 | 25 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons1
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison |
|---|
| CHF Peptide vs Non CHF Peptide: serious adverse events |
Source Trial comparisons
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01584518
GET https://conductscience.org/api/trials/v1/NCT01584518/registered